市場調査レポート

商品コード

不妊治療サービスの世界市場：市場シェアおよびランキング・全体の売上および需要予測 (2024-2030年)

Infertility Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

出版日: 2024年02月06日 | 発行: QYResearch

| ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 3,950 619,202円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,925 928,803円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 7,900 1,238,404円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の不妊治療サービスの市場規模は、2023年の71億9,114万米ドルから、予測期間中は7.41%のCAGRで推移し、2030年には118億2,164万米ドルの規模に成長すると予測されています。

北米市場は、2023年の23億1,770万米ドルから、予測期間中は7.39％のCAGRで推移し、2030年には38億3,440万米ドルに達すると予測されています。アジア太平洋市場は、2023年の32億1,156万米ドルから、同期間中は8％のCAGRで推移し、2030年には54億5,441万米ドルに達すると予測されています。欧州市場は、2023年の14億515万米ドルから、6.43％のCAGRで推移し、2030年には21億7,109万米ドルに達すると予測されています。

当レポートでは、世界の不妊治療サービスの市場を調査し、市場および製品の概要、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・用途別の内訳、地域・主要国別の詳細分析、競合環境、市場シェア、ランキング、主要企業のプロファイルなどをまとめています。

List of Tables

Table 1. Infertility Services Market Trends
Table 2. Infertility Services Market Drivers & Opportunity
Table 3. Infertility Services Market Challenges
Table 4. Infertility Services Market Restraints
Table 5. Global Infertility Services Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Infertility Services Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Infertility Services Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Infertility Services Product Type
Table 9. Global Infertility Services Companies Market Concentration Ratio (CR5 and HHI)
Table 10. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2023)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Global Infertility Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Infertility Services Sales Value by Type (2019-2024) & (US$ Million)
Table 14. Global Infertility Services Sales Value by Type (2025-2030) & (US$ Million)
Table 15. Global Infertility Services Sales Market Share in Value by Type (2019-2024)
Table 16. Global Infertility Services Sales Market Share in Value by Type (2025-2030)
Table 17. Global Infertility Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Infertility Services Sales Value by Application (2019-2024) & (US$ Million)
Table 19. Global Infertility Services Sales Value by Application (2025-2030) & (US$ Million)
Table 20. Global Infertility Services Sales Market Share in Value by Application (2019-2024)
Table 21. Global Infertility Services Sales Market Share in Value by Application (2025-2030)
Table 22. Global Infertility Services Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
Table 23. Global Infertility Services Sales Value by Region (2019-2024) & (US$ Million)
Table 24. Global Infertility Services Sales Value by Region (2025-2030) & (US$ Million)
Table 25. Global Infertility Services Sales Value by Region (2019-2024) & (%)
Table 26. Global Infertility Services Sales Value by Region (2025-2030) & (%)
Table 27. Key Countries/Regions Infertility Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 28. Key Countries/Regions Infertility Services Sales Value, (2019-2024) & (US$ Million)
Table 29. Key Countries/Regions Infertility Services Sales Value, (2025-2030) & (US$ Million)
Table 30. Ferring Pharmaceuticals Basic Information List
Table 31. Ferring Pharmaceuticals Description and Business Overview
Table 32. Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
Table 33. Revenue (US$ Million) in Infertility Services Business of Ferring Pharmaceuticals (2019-2024)
Table 34. Merck Basic Information List
Table 35. Merck Description and Business Overview
Table 36. Merck Infertility Services Products, Services and Solutions
Table 37. Revenue (US$ Million) in Infertility Services Business of Merck (2019-2024)
Table 38. Jinxin Fertility Basic Information List
Table 39. Jinxin Fertility Description and Business Overview
Table 40. Jinxin Fertility Infertility Services Products, Services and Solutions
Table 41. Revenue (US$ Million) in Infertility Services Business of Jinxin Fertility (2019-2024)
Table 42. Vitrolife Basic Information List
Table 43. Vitrolife Description and Business Overview
Table 44. Vitrolife Infertility Services Products, Services and Solutions
Table 45. Revenue (US$ Million) in Infertility Services Business of Vitrolife (2019-2024)
Table 46. Mayo Clinic Basic Information List
Table 47. Mayo Clinic Description and Business Overview
Table 48. Mayo Clinic Infertility Services Products, Services and Solutions
Table 49. Revenue (US$ Million) in Infertility Services Business of Mayo Clinic (2019-2024)
Table 50. LIVZON Basic Information List
Table 51. LIVZON Description and Business Overview
Table 52. LIVZON Infertility Services Products, Services and Solutions
Table 53. Revenue (US$ Million) in Infertility Services Business of LIVZON (2019-2024)
Table 54. Abbott Basic Information List
Table 55. Abbott Description and Business Overview
Table 56. Abbott Infertility Services Products, Services and Solutions
Table 57. Revenue (US$ Million) in Infertility Services Business of Abbott (2019-2024)
Table 58. Monash IVF Basic Information List
Table 59. Monash IVF Description and Business Overview
Table 60. Monash IVF Infertility Services Products, Services and Solutions
Table 61. Revenue (US$ Million) in Infertility Services Business of Monash IVF (2019-2024)
Table 62. Monash IVF Recent Developments
Table 63. CARE facility Basic Information List
Table 64. CARE facility Description and Business Overview
Table 65. CARE facility Infertility Services Products, Services and Solutions
Table 66. Revenue (US$ Million) in Infertility Services Business of CARE facility (2019-2024)
Table 67. Theramex Basic Information List
Table 68. Theramex Description and Business Overview
Table 69. Theramex Infertility Services Products, Services and Solutions
Table 70. Revenue (US$ Million) in Infertility Services Business of Theramex (2019-2024)
Table 71. TriHealth Basic Information List
Table 72. TriHealth Description and Business Overview
Table 73. TriHealth Infertility Services Products, Services and Solutions
Table 74. Revenue (US$ Million) in Infertility Services Business of TriHealth (2019-2024)
Table 75. NMC Health Basic Information List
Table 76. NMC Health Description and Business Overview
Table 77. NMC Health Infertility Services Products, Services and Solutions
Table 78. Revenue (US$ Million) in Infertility Services Business of NMC Health (2019-2024)
Table 79. CooperSurgical Basic Information List
Table 80. CooperSurgical Description and Business Overview
Table 81. CooperSurgical Infertility Services Products, Services and Solutions
Table 82. Revenue (US$ Million) in Infertility Services Business of CooperSurgical (2019-2024)
Table 83. Irvine Scientific Basic Information List
Table 84. Irvine Scientific Description and Business Overview
Table 85. Irvine Scientific Infertility Services Products, Services and Solutions
Table 86. Revenue (US$ Million) in Infertility Services Business of Irvine Scientific (2019-2024)
Table 87. Virtus Health Basic Information List
Table 88. Virtus Health Description and Business Overview
Table 89. Virtus Health Infertility Services Products, Services and Solutions
Table 90. Revenue (US$ Million) in Infertility Services Business of Virtus Health (2019-2024)
Table 91. CinnaGen Basic Information List
Table 92. CinnaGen Description and Business Overview
Table 93. CinnaGen Infertility Services Products, Services and Solutions
Table 94. Revenue (US$ Million) in Infertility Services Business of CinnaGen (2019-2024)
Table 95. OB GYN Associates Basic Information List
Table 96. OB GYN Associates Description and Business Overview
Table 97. OB GYN Associates Infertility Services Products, Services and Solutions
Table 98. Revenue (US$ Million) in Infertility Services Business of OB GYN Associates (2019-2024)
Table 99. Caerus Biotech Basic Information List
Table 100. Caerus Biotech Description and Business Overview
Table 101. Caerus Biotech Infertility Services Products, Services and Solutions
Table 102. Revenue (US$ Million) in Infertility Services Business of Caerus Biotech (2019-2024)
Table 103. InVitroCare Basic Information List
Table 104. InVitroCare Description and Business Overview
Table 105. InVitroCare Infertility Services Products, Services and Solutions
Table 106. Revenue (US$ Million) in Infertility Services Business of InVitroCare (2019-2024)
Table 107. INVO Bioscience Basic Information List
Table 108. INVO Bioscience Description and Business Overview
Table 109. INVO Bioscience Infertility Services Products, Services and Solutions
Table 110. Revenue (US$ Million) in Infertility Services Business of INVO Bioscience (2019-2024)
Table 111. INVO Bioscience Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infertility Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Infertility Services Sales Value (2019-2030) & (US$ Million)
Figure 3. Infertility Services Report Years Considered
Figure 4. Global Infertility Services Players Revenue Ranking (2023) & (US$ Million)
Figure 5. The 5 Largest Companies in the World: Market Share by Infertility Services Revenue in 2023
Figure 6. The 10 Largest Companies in the World: Market Share by Infertility Services Revenue in 2023
Figure 7. Infertility Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Assisted Reproductive Technology (ART) Picture
Figure 9. Infertility Drug Services Picture
Figure 10. Global Infertility Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Infertility Services Sales Value Market Share by Type, 2023 & 2030
Figure 12. Global Infertility Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Infertility Services Sales Value Market Share by Application, 2023 & 2030
Figure 14. North America Infertility Services Sales Value (2019-2030) & (US$ Million)
Figure 15. North America Infertility Services Sales Value by Country (%), 2023 VS 2030
Figure 16. Europe Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 17. Europe Infertility Services Sales Value by Country (%), 2023 VS 2030
Figure 18. Asia Pacific Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 19. Asia Pacific Infertility Services Sales Value by Region (%), 2023 VS 2030
Figure 20. South America Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 21. South America Infertility Services Sales Value by Country (%), 2023 VS 2030
Figure 22. Middle East & Africa Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 23. Middle East & Africa Infertility Services Sales Value by Country (%), 2023 VS 2030
Figure 24. United States Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 25. United States Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 26. United States Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 27. Europe Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 28. Europe Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 29. Europe Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 30. China Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 31. China Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 32. China Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 33. Japan Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 34. Japan Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 35. Japan Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 36. South Korea Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 37. South Korea Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 38. South Korea Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 39. Southeast Asia Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 41. Southeast Asia Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 42. India Infertility Services Sales Value, (2019-2030) & (US$ Million)
Figure 43. India Infertility Services Sales Value by Type (%), 2023 VS 2030
Figure 44. India Infertility Services Sales Value by Application (%), 2023 VS 2030
Figure 45. Infertility Services Industrial Chain
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed 119

The global market for Infertility Services was estimated to be worth US$ 7,191.14 million in 2023 and is forecast to a readjusted size of US$ 11,821.64 million by 2030 with a CAGR of 7.41% during the forecast period 2024-2030.

North American market for Infertility Services was valued at $ 2,317.7 million in 2023 and will reach $ 3,834.4 million by 2030, at a CAGR of 7.39% during the forecast period of 2024 through 2030.

Asia-Pacific market for Infertility Services was valued at $ 3,211.56 million in 2023 and will reach $ 5,454.41 million by 2030, at a CAGR of 8% during the forecast period of 2024 through 2030.

Europe market for Infertility Services was valued at $ 1,405.15 million in 2023 and will reach $ 2,171.09 million by 2030, at a CAGR of 6.43% during the forecast period of 2024 through 2030.

The global key companies of Infertility Services include: Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, Jinxin Fertility, LIVZON, and Abbott, etc. In 2023, the global five largest players hold a share approximately 23.32% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Infertility Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infertility Services by region & country, by Type, and by Application.

The Infertility Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Services.

Market Segmentation

By Company

Ferring Pharmaceuticals
Merck
Jinxin Fertility
Vitrolife
Mayo Clinic
LIVZON
Abbott
Monash IVF
CARE Facility
Theramex
TriHealth
NMC Health
CooperSurgical
Irvine Scientific
Virtus Health
CinnaGen
OB GYN Associates
Caerus Biotech
InVitroCare
INVO Bioscience

Segment by Type

Assisted Reproductive Technology (ART)
Infertility Drug Services
Others

Segment by Application

Male
Female

By Region

North America
- United States
- Canada

Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific

Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe

South America
- Mexico
- Brazil
- Rest of South America

Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Infertility Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Infertility Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Infertility Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Infertility Services Product Introduction
1.2 Global Infertility Services Market Size Forecast (2019-2030)
1.3 Infertility Services Market Trends & Drivers
- 1.3.1 Infertility Services Industry Trends
- 1.3.2 Infertility Services Market Drivers & Opportunity
- 1.3.3 Infertility Services Market Challenges
- 1.3.4 Infertility Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infertility Services Players Revenue Ranking (2023)
2.2 Global Infertility Services Revenue by Company (2019-2024)
2.3 Key Companies Infertility Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infertility Services Product Offered
2.5 Infertility Services Market Competitive Analysis
- 2.5.1 Infertility Services Market Concentration Rate (2019-2024)
- 2.5.2 Global 5 and 10 Largest Companies by Infertility Services Revenue in 2023
- 2.5.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2023)
2.6 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type
- 3.1.1 Assisted Reproductive Technology (ART)
- 3.1.2 Infertility Drug Services
- 3.1.3 Others
3.2 Global Infertility Services Sales Value by Type
- 3.2.1 Global Infertility Services Sales Value by Type (2019 VS 2023 VS 2030)
- 3.2.2 Global Infertility Services Sales Value, by Type (2019-2030)
- 3.2.3 Global Infertility Services Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application
4.2 Global Infertility Services Sales Value by Application
- 4.2.1 Global Infertility Services Sales Value by Application (2019 VS 2023 VS 2030)
- 4.2.2 Global Infertility Services Sales Value, by Application (2019-2030)
- 4.2.3 Global Infertility Services Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infertility Services Sales Value by Region
- 5.1.1 Global Infertility Services Sales Value by Region: 2019 VS 2023 VS 2030
- 5.1.2 Global Infertility Services Sales Value by Region (2019-2024)
- 5.1.3 Global Infertility Services Sales Value by Region (2025-2030)
- 5.1.4 Global Infertility Services Sales Value by Region (%), (2019-2030)
5.2 North America
- 5.2.1 North America Infertility Services Sales Value, 2019-2030
- 5.2.2 North America Infertility Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
- 5.3.1 Europe Infertility Services Sales Value, 2019-2030
- 5.3.2 Europe Infertility Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
- 5.4.1 Asia Pacific Infertility Services Sales Value, 2019-2030
- 5.4.2 Asia Pacific Infertility Services Sales Value by Region (%), 2023 VS 2030
5.5 South America
- 5.5.1 South America Infertility Services Sales Value, 2019-2030
- 5.5.2 South America Infertility Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Infertility Services Sales Value, 2019-2030
- 5.6.2 Middle East & Africa Infertility Services Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infertility Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infertility Services Sales Value, 2019-2030
6.3 United States
- 6.3.1 United States Infertility Services Sales Value, 2019-2030
- 6.3.2 United States Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.3.3 United States Infertility Services Sales Value by Application, 2023 VS 2030
6.4 Europe
- 6.4.1 Europe Infertility Services Sales Value, 2019-2030
- 6.4.2 Europe Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.4.3 Europe Infertility Services Sales Value by Application, 2023 VS 2030
6.5 China
- 6.5.1 China Infertility Services Sales Value, 2019-2030
- 6.5.2 China Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.5.3 China Infertility Services Sales Value by Application, 2023 VS 2030
6.6 Japan
- 6.6.1 Japan Infertility Services Sales Value, 2019-2030
- 6.6.2 Japan Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.6.3 Japan Infertility Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
- 6.7.1 South Korea Infertility Services Sales Value, 2019-2030
- 6.7.2 South Korea Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.7.3 South Korea Infertility Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
- 6.8.1 Southeast Asia Infertility Services Sales Value, 2019-2030
- 6.8.2 Southeast Asia Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.8.3 Southeast Asia Infertility Services Sales Value by Application, 2023 VS 2030
6.9 India
- 6.9.1 India Infertility Services Sales Value, 2019-2030
- 6.9.2 India Infertility Services Sales Value by Type (%), 2023 VS 2030
- 6.9.3 India Infertility Services Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ferring Pharmaceuticals
- 7.1.1 Ferring Pharmaceuticals Profile
- 7.1.2 Ferring Pharmaceuticals Main Business
- 7.1.3 Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
- 7.1.4 Ferring Pharmaceuticals Infertility Services Revenue (US$ Million) & (2019-2024)
7.2 Merck
- 7.2.1 Merck Profile
- 7.2.2 Merck Main Business
- 7.2.3 Merck Infertility Services Products, Services and Solutions
- 7.2.4 Merck Infertility Services Revenue (US$ Million) & (2019-2024)
7.3 Jinxin Fertility
- 7.3.1 Jinxin Fertility Profile
- 7.3.2 Jinxin Fertility Main Business
- 7.3.3 Jinxin Fertility Infertility Services Products, Services and Solutions
- 7.3.4 Jinxin Fertility Infertility Services Revenue (US$ Million) & (2019-2024)
7.4 Vitrolife
- 7.4.1 Vitrolife Profile
- 7.4.2 Vitrolife Main Business
- 7.4.3 Vitrolife Infertility Services Products, Services and Solutions
- 7.4.4 Vitrolife Infertility Services Revenue (US$ Million) & (2019-2024)
7.5 Mayo Clinic
- 7.5.1 Mayo Clinic Profile
- 7.5.2 Mayo Clinic Main Business
- 7.5.3 Mayo Clinic Infertility Services Products, Services and Solutions
- 7.5.4 Mayo Clinic Infertility Services Revenue (US$ Million) & (2019-2024)
7.6 LIVZON
- 7.6.1 LIVZON Profile
- 7.6.2 LIVZON Main Business
- 7.6.3 LIVZON Infertility Services Products, Services and Solutions
- 7.6.4 LIVZON Infertility Services Revenue (US$ Million) & (2019-2024)
7.7 Abbott
- 7.7.1 Abbott Profile
- 7.7.2 Abbott Main Business
- 7.7.3 Abbott Infertility Services Products, Services and Solutions
- 7.7.4 Abbott Infertility Services Revenue (US$ Million) & (2019-2024)
7.8 Monash IVF
- 7.8.1 Monash IVF Profile
- 7.8.2 Monash IVF Main Business
- 7.8.3 Monash IVF Infertility Services Products, Services and Solutions
- 7.8.4 Monash IVF Infertility Services Revenue (US$ Million) & (2019-2024)
- 7.8.5 Monash IVF Recent Developments
7.9 CARE facility
- 7.9.1 CARE facility Profile
- 7.9.2 CARE facility Main Business
- 7.9.3 CARE facility Infertility Services Products, Services and Solutions
- 7.9.4 CARE facility Infertility Services Revenue (US$ Million) & (2019-2024)
7.10 Theramex
- 7.10.1 Theramex Profile
- 7.10.2 Theramex Main Business
- 7.10.3 Theramex Infertility Services Products, Services and Solutions
- 7.10.4 Theramex Infertility Services Revenue (US$ Million) & (2019-2024)
7.11 TriHealth
- 7.11.1 TriHealth Profile
- 7.11.2 TriHealth Main Business
- 7.11.3 TriHealth Infertility Services Products, Services and Solutions
- 7.11.4 TriHealth Infertility Services Revenue (US$ Million) & (2019-2024)
7.12 NMC Health
- 7.12.1 NMC Health Profile
- 7.12.2 NMC Health Main Business
- 7.12.3 NMC Health Infertility Services Products, Services and Solutions
- 7.12.4 NMC Health Infertility Services Revenue (US$ Million) & (2019-2024)
7.13 CooperSurgical
- 7.13.1 CooperSurgical Profile
- 7.13.2 CooperSurgical Main Business
- 7.13.3 CooperSurgical Infertility Services Products, Services and Solutions
- 7.13.4 CooperSurgical Infertility Services Revenue (US$ Million) & (2019-2024)
7.14 Irvine Scientific
- 7.14.1 Irvine Scientific Profile
- 7.14.2 Irvine Scientific Main Business
- 7.14.3 Irvine Scientific Infertility Services Products, Services and Solutions
- 7.14.4 Irvine Scientific Infertility Services Revenue (US$ Million) & (2019-2024)
7.15 Virtus Health
- 7.15.1 Virtus Health Profile
- 7.15.2 Virtus Health Main Business
- 7.15.3 Virtus Health Infertility Services Products, Services and Solutions
- 7.15.4 Virtus Health Infertility Services Revenue (US$ Million) & (2019-2024)
7.16 CinnaGen
- 7.16.1 CinnaGen Profile
- 7.16.2 CinnaGen Main Business
- 7.16.3 CinnaGen Infertility Services Products, Services and Solutions
- 7.16.4 CinnaGen Infertility Services Revenue (US$ Million) & (2019-2024)
7.17 OB GYN Associates
- 7.17.1 OB GYN Associates Profile
- 7.17.2 OB GYN Associates Main Business
- 7.17.3 OB GYN Associates Infertility Services Products, Services and Solutions
- 7.17.4 OB GYN Associates Infertility Services Revenue (US$ Million) & (2019-2024)
7.18 Caerus Biotech
- 7.18.1 Caerus Biotech Profile
- 7.18.2 Caerus Biotech Main Business
- 7.18.3 Caerus Biotech Infertility Services Products, Services and Solutions
- 7.18.4 Caerus Biotech Infertility Services Revenue (US$ Million) & (2019-2024)
7.19 InVitroCare
- 7.19.1 InVitroCare Profile
- 7.19.2 InVitroCare Main Business
- 7.19.3 InVitroCare Infertility Services Products, Services and Solutions
- 7.19.4 InVitroCare Infertility Services Revenue (US$ Million) & (2019-2024)
7.20 INVO Bioscience
- 7.20.1 INVO Bioscience Profile
- 7.20.2 INVO Bioscience Main Business
- 7.20.3 INVO Bioscience Infertility Services Products, Services and Solutions
- 7.20.4 INVO Bioscience Infertility Services Revenue (US$ Million) & (2019-2024)
- 7.20.5 INVO Bioscience Recent Developments

8 Industry Chain Analysis

8.1 Infertility Services Industrial Chain
8.2 Infertility Services Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

不妊治療サービスの世界市場：市場シェアおよびランキング・全体の売上および需要予測 (2024-2030年)

Infertility Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

目次

第1章市場概要

第2章競合分析：企業別

第3章タイプ別セグメント

第4章用途別セグメント

第5章地域別セグメント

第6章主要国/地域別セグメント

第7章企業プロファイル

第8章産業チェーン分析

第9章調査結果・総論

第10章付録

List of Tables

List of Figures

Market Segmentation

By Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Table of Contents

1 Market Overview

2 Competitive Analysis by Company

3 Segmentation by Type

4 Segmentation by Application

5 Segmentation by Region

6 Segmentation by Key Countries/Regions

7 Company Profiles

8 Industry Chain Analysis

9 Research Findings and Conclusion

10 Appendix

不妊治療サービスの世界市場：市場シェアおよびランキング・全体の売上および需要予測 (2024-2030年)

Infertility Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

目次

第1章 市場概要

第2章 競合分析：企業別

第3章 タイプ別セグメント

第4章 用途別セグメント

第5章 地域別セグメント

第6章 主要国/地域別セグメント

第7章 企業プロファイル

第8章 産業チェーン分析

第9章 調査結果・総論

第10章 付録

List of Tables

List of Figures

Market Segmentation

By Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Table of Contents

1 Market Overview

2 Competitive Analysis by Company

3 Segmentation by Type

4 Segmentation by Application

5 Segmentation by Region

6 Segmentation by Key Countries/Regions

7 Company Profiles

8 Industry Chain Analysis

9 Research Findings and Conclusion

10 Appendix

第1章市場概要

第2章競合分析：企業別

第3章タイプ別セグメント

第4章用途別セグメント

第5章地域別セグメント

第6章主要国/地域別セグメント

第7章企業プロファイル

第8章産業チェーン分析

第9章調査結果・総論

第10章付録